Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents As Second-Line Biologics in Crohn's Disease
Digestive Diseases and Sciences（2023）
关键词
Crohn's disease,Ustekinumab,Anti-TNF,Comparative effectiveness,Comparative safety,Population-based study
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要